Suppr超能文献

肿瘤生态进化对肾细胞癌样本采集的影响

The Impact of Tumor Eco-Evolution in Renal Cell Carcinoma Sampling.

作者信息

López-Fernández Estíbaliz, López José I

机构信息

FISABIO Foundation, 46020 Valencia, Spain.

Department of Health Sciences, European University of Valencia, Laureate Universities, 46023 Valencia, Spain.

出版信息

Cancers (Basel). 2018 Dec 4;10(12):485. doi: 10.3390/cancers10120485.

Abstract

Malignant tumors behave dynamically as cell communities governed by ecological principles. Massive sequencing tools are unveiling the true dimension of the heterogeneity of these communities along their evolution in most human neoplasms, clear cell renal cell carcinomas (CCRCC) included. Although initially thought to be purely stochastic processes, very recent genomic analyses have shown that temporal tumor evolution in CCRCC may follow some deterministic pathways that give rise to different clones and sub-clones randomly spatially distributed across the tumor. This fact makes each case unique, unrepeatable and unpredictable. Precise and complete molecular information is crucial for patients with cancer since it may help in establishing a personalized therapy. Intratumor heterogeneity (ITH) detection relies on the correctness of tumor sampling and this is part of the pathologist's daily work. International protocols for tumor sampling are insufficient today. They were conceived decades ago, when ITH was not an issue, and have remained unchanged until now. Noteworthy, an alternative and more efficient sampling method for detecting ITH has been developed recently. This new method, called multisite tumor sampling (MSTS), is specifically addressed to large tumors that are impossible to be totally sampled, and represent an opportunity to improve ITH detection without extra costs.

摘要

恶性肿瘤作为受生态原则支配的细胞群落,表现出动态变化。大规模测序工具正在揭示这些群落在大多数人类肿瘤(包括透明细胞肾细胞癌,CCRCC)进化过程中的异质性真实维度。尽管最初认为这纯粹是随机过程,但最近的基因组分析表明,CCRCC中的肿瘤时间进化可能遵循一些确定性途径,这些途径会产生不同的克隆和亚克隆,它们在肿瘤中随机地空间分布。这一事实使得每个病例都是独特的、不可重复的且不可预测的。精确和完整的分子信息对于癌症患者至关重要,因为它可能有助于制定个性化治疗方案。肿瘤内异质性(ITH)检测依赖于肿瘤采样的正确性,而这是病理学家日常工作的一部分。如今国际肿瘤采样方案并不完善。它们是几十年前制定的,当时ITH还不是一个问题,并且至今仍未改变。值得注意的是,最近开发了一种用于检测ITH的替代且更有效的采样方法。这种新方法称为多部位肿瘤采样(MSTS),专门针对无法完全采样的大肿瘤,是一个无需额外成本就能改进ITH检测的机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ec/6316833/44da9abdc4b7/cancers-10-00485-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验